Mark Kroll

Mark W.
Kroll is currently an Independent Director at Haemonetics Corp.
since 2006, a Director at Medisyn Technologies, Inc., and a Director at the San Francisco Opera Association.
Former positions include Director at Recombinetics, Inc., TriVirix International, Inc., NewCardio, Inc. (2011-2012), Ionix Medical, Inc., and Secretary at Harbinger Medical, Inc. (1993-2009).
Served as Independent Director at Axon Enterprise, Inc. from 2003 to 2024.
Held executive roles including Vice President-Research at MGC Diagnostics Corp.
in 1995, SVP & CTO-Cardiac Rhythm Management Division at St. Jude Medical LLC from 1995 to 2005, Vice President-Research & Development at Vital Health Technologies, Inc. in 1991, and Vice President-Research & Development at Intercomp Co. in 1985.
Education includes an MBA from the University of St. Thomas (Texas) in 1990, undergraduate degree in 1975, graduate degree in 1983, and doctorate in 1987 from the College of Science & Engineering, and a doctorate from the University of Minnesota.